Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company ...
Oxford Brain Diagnostics (OBD), a pioneer in quantitative brain biology, today announced new research demonstrating that its ...
WELTRUZA ™ (olanzapine) for extended-release injectable suspension is the first and only once-monthly subcutaneous ...
(TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical-stage pharmaceutical company dedicated to the research ...
Cash balance of $116 million as of June 30, 2026 expected to fund operations through the end of 2028, supporting anticipated ...
Guardant360 CDx can now help identify cancer mutations earlier and drive improved patient outcomes in major global ...
AbCellera (Nasdaq: ABCL) today announced an upcoming poster presentation of Phase 1/2 data on ABCL635 at The Menopause ...
Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization ...
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...
Ginkgo Bioworks (NYSE: DNA) today announced that it will provide in-kind access to its autonomous laboratory in Boston to ...
About Nuvectis Pharma, Inc. Nuvectis Pharma, Inc. is a clinical stage biopharmaceutical company focused on the development of ...
Dean Merder to serve as Executive Advisor to the Chairman, following eight years of leadership. WASHINGTON, Ind.--(BUSINESS ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results